Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-01-13Clinical Trial Update: Evaluating "Health at Every Size"(HAES) as an Alternative Obesity Treatment Model [NA]
This clinical trial update reports the completion of a study evaluating the Health at Every Size approach as an alternative obesity treatmen…
-
CLINICAL_TRIALS trial_result · 2010-01-13Clinical Trial Update: Effects of Aliskiren/Amlodipine Versus Amlodipine Monotherapy on Ankle-foot Volume in Hypertensive Patients [Phase 4]
Phase 4 clinical trial comparing aliskiren/amlodipine against amlodipine alone to assess effects on ankle-foot volume in hypertensive patien…
-
CLINICAL_TRIALS trial_result · 2010-01-12Clinical Trial Update: Effect of Strict Blood Pressure Control and ACE-Inhibition on Progression of Chronic Renal Failure in Pediatric Patients [Phase 3]
Phase 3 trial in pediatric patients evaluated whether strict blood pressure control combined with ACE-inhibition slows progression of chroni…
-
CLINICAL_TRIALS research · 2010-01-05Clinical Trial Update: Angiogenesis Inhibitors and Hypertension: Clinical Aspects
Clinical trial update from Erasmus Medical Center examining the relationship between angiogenesis inhibitors and hypertension. The trial sta…
-
FDA approval · 2009-12-28FDA Approved: BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sandoz Inc)
FDA approved a supplemental application for a generic fixed-dose combination of benazepril hydrochloride and hydrochlorothiazide from Sandoz…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2009-12-24FDA Approved: BENAZEPRIL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for benazepril hydrochloride from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2009-12-24Clinical Trial Update: Aliskiren Versus Ramipril on Antiproteinuric Effect in Hypertensive, Type 2 Diabetic Patients With Microalbuminuria [Phase 4]
Phase 4 clinical trial update comparing aliskiren versus ramipril for antiproteinuric effects in hypertensive patients with type 2 diabetes …
-
CLINICAL_TRIALS trial_result · 2009-12-23Clinical Trial Update: Post-Marketing Surveillance Of Olmesartan Medoxomil In Combination With Hydrochlorothiazide
This clinical trial update reports results from post-marketing surveillance of the olmesartan medoxomil and hydrochlorothiazide combination …
-
CLINICAL_TRIALS trial_result · 2009-12-22Clinical Trial Update: Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension [Phase 3]
A Phase 3 trial comparing fixed-dose combinations of telmisartan/amlodipine at 80/10 and 40/10 versus amlodipine 10 in resistant hypertensio…
-
FDA label_change · 2009-12-22FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA overview of a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) submitted by Novartis, likely invol…
-
FDA approval · 2009-12-22FDA Approved: CARVEDILOL — Original Application (Advagen Pharma Limited)
FDA approves the original application for a generic carvedilol product by Advagen Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2009-12-18Clinical Trial Update: Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure
An update on a completed AstraZeneca-sponsored trial evaluating target organ impairment in patients with hypertension. The study status is c…
-
CLINICAL_TRIALS trial_result · 2009-12-17Clinical Trial Update: The Impact of Hospitalization on Ambulatory Blood Pressure and Intraocular Pressure
The trial update reports completed results studying how hospitalization influences ambulatory blood pressure and intraocular pressure.
-
FDA approval · 2009-12-16FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Verapamil Hydrochloride filed by Wilshire Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2009-12-16Clinical Trial Update: Cardiovascular-Protective Effects of Herbal Medicine Danshen-Gegen [Phase 2]
Phase 2 trial evaluating the cardiovascular-protective effects of the Danshen-Gegen herbal medicine in hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension [Phase 3]
Phase 3 trial comparing two fixed-dose combinations of telmisartan/amlodipine (80/5 and 40/5) with amlodipine alone (5 or 10 mg) in resistan…
-
CLINICAL_TRIALS trial_result · 2009-12-15Clinical Trial Update: Study of Atenolol Influence on Blood Pressure During Resistance Exercise [Phase 4]
A phase 4 trial evaluated how atenolol influences blood pressure during resistance exercise. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2009-12-14Clinical Trial Update: Comparison of Diuretic-based With Non-diuretic Based Hypertension Therapy Using Echocardiographic Measures [NA]
A completed clinical trial comparing diuretic-based hypertension therapy with non-diuretic based therapy using echocardiographic measures.
-
CLINICAL_TRIALS trial_result · 2009-12-09Clinical Trial Update: Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age [Phase 3]
Phase 3 clinical trial update assessing the efficacy, safety, and pharmacokinetics of candesartan cilexetil in hypertensive paediatric subje…
-
CLINICAL_TRIALS trial_result · 2009-12-07Clinical Trial Update: Irbesartan in Hypertension [Phase 4]
This document provides an update on a Phase 4 clinical trial of irbesartan for hypertension, with the study status listed as completed. The …
-
FDA approval · 2009-12-04FDA Approved: AMLODIPINE BESYLATE — Supplemental Application (Cipla USA Inc.)
FDA approves a supplemental application for Cipla USA's amlodipine besylate, a generic product containing amlodipine besylate. The approval …
-
FDA approval · 2009-12-03FDA Approved: VERAPAMIL HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for verapamil hydrochloride by Mylan Pharmaceuticals Inc., enabling the generic version to be market…
-
FDA approval · 2009-12-03FDA Approved: CLONIDINE — Original Application (TruPharma, LLC)
FDA approved a clonidine product via an Original Application from TruPharma, LLC.
-
CLINICAL_TRIALS research · 2009-12-03Clinical Trial Update: The Effect of Hibiscus Sabdariffa L. Tea on Blood Pressure [Phase 1, Phase 2]
This document reports a clinical trial update evaluating the effect of Hibiscus sabdariffa L. tea on blood pressure in Phase 1 and Phase 2 s…
-
CLINICAL_TRIALS research · 2009-12-02Clinical Trial Update: Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD) [Phase 2]
Clinical trial update on a Phase 2 efficacy and safety study for second-line treatment in patients with hypertension associated with autosom…